{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:42:15Z","timestamp":1789472535571,"version":"build-2803163510"},"reference-count":117,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No: 81302711"],"award-info":[{"award-number":["No: 81302711"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","nanomedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.nano.2016.08.007","type":"journal-article","created":{"date-parts":[[2016,8,24]],"date-time":"2016-08-24T05:31:01Z","timestamp":1472016661000},"page":"455-469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"title":["Safety of nanosuspensions in drug delivery"],"prefix":"10.1016","volume":"13","author":[{"given":"Lulu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9465-2610","authenticated-orcid":false,"given":"Yancai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2016.08.007_bb0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pharmthera.2008.07.001","article-title":"Health effects related to nanoparticle exposures: environmental, health and safety considerations for assessing hazards and risks","volume":"120","author":"Warheit","year":"2008","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.nano.2016.08.007_bb0010","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1517\/17425247.2015.1043886","article-title":"Drug nanosuspensions a ZIP tool between traditional and innovative pharmaceutical formulations","volume":"12","author":"Cavalli","year":"2015","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.nano.2016.08.007_bb0015","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.ijpharm.2015.09.021","article-title":"Nanosuspensions of poorly water-soluble drugs prepared by bottom-up technologies","volume":"495","author":"Du","year":"2015","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0020","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ijpharm.2015.08.052","article-title":"Particle size tailoring of ursolic acid nanosuspensions for improved anticancer activity by controlled antisolvent precipitation","volume":"494","author":"Wang","year":"2015","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0025","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jconrel.2013.08.006","article-title":"Stability of nanosuspensions in drug delivery","volume":"172","author":"Wang","year":"2013","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2016.08.007_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2011.01.007","article-title":"State of the art of nanocrystals \u2013 special features, production, nanotoxicology aspects and intracellular delivery","volume":"78","author":"Muller","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0035","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jconrel.2012.03.013","article-title":"Drug nanocrystals: in vivo performances","volume":"160","author":"Gao","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2016.08.007_bb0040","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.ijpharm.2011.11.031","article-title":"In vitro and in vivo evaluation of camptothecin nanosuspension: a novel formulation with high antitumor efficacy and low toxicity","volume":"423","author":"Yao","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0045","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ijpharm.2013.04.057","article-title":"Development of PIK-75 nanosuspension formulation with enhanced delivery efficiency and cytotoxicity for targeted anti-cancer therapy","volume":"450","author":"Talekar","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0050","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ijpharm.2012.10.021","article-title":"In vitro and in vivo anticancer activity of a novel puerarin nanosuspension against colon cancer, with high efficacy and low toxicity","volume":"441","author":"Wang","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0055","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1002\/jps.24098","article-title":"A brief literature and patent review of nanosuspensions to a final drug product","volume":"103","author":"Chin","year":"2014","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nano.2016.08.007_bb0060","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ssci.2013.11.018","article-title":"Safety aspects of nanotechnology based activity","volume":"63","author":"Seal","year":"2014","journal-title":"Saf Sci"},{"key":"10.1016\/j.nano.2016.08.007_bb0065","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/489350a","article-title":"Nano-safety studies urged in China","volume":"489","author":"Qiu","year":"2012","journal-title":"Nat News"},{"key":"10.1016\/j.nano.2016.08.007_bb0070","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/460937a","article-title":"Nanoparticle safety in doubt","volume":"460","author":"Gilbert","year":"2009","journal-title":"Nat News"},{"key":"10.1016\/j.nano.2016.08.007_bb0075","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jconrel.2014.03.030","article-title":"Engineered nanocrystal technology: in-vivo fate, targeting and applications in drug delivery","volume":"183","author":"Pawar","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2016.08.007_bb0080","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.2174\/1381612821666150901103208","article-title":"Nanotechnology in drug delivery: safety and toxicity issues","volume":"21","author":"Jain","year":"2015","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.nano.2016.08.007_bb0085","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijpharm.2014.03.048","article-title":"Brinzolamide nanocrystal formulations for ophthalmic delivery: reduction of elevated intraocular pressure in vivo","volume":"467","author":"Tuomela","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0090","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.yrtph.2008.10.008","article-title":"Review of health safety aspects of nanotechnologies in food production","volume":"53","author":"Bouwmeester","year":"2009","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.nano.2016.08.007_bb0095","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ijpharm.2013.07.023","article-title":"Sildenafil citrate monohydrate-cyclodextrin nanosuspension complexes for use in metered-dose inhalers","volume":"455","author":"Sawatdee","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0100","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijpharm.2010.12.013","article-title":"Universal wet-milling technique to prepare oral nanosuspension focused on discovery and preclinical animal studies \u2013 development of particle design method","volume":"405","author":"Niwa","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0105","first-page":"1117","article-title":"Nanotoxicology and nanoparticle safety in biomedical designs","volume":"6","author":"Biazar","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0110","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ijpharm.2012.12.036","article-title":"D-alpha-tocopherol acid polyethylene glycol 1000 succinate, an effective stabilizer during solidification transformation of baicalin nanosuspensions","volume":"443","author":"Yue","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0115","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ijpharm.2013.06.050","article-title":"Study on formability of solid nanosuspensions during nanodispersion and solidification: I. Novel role of stabilizer\/drug property","volume":"454","author":"Yue","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0120","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/24\/46\/465101","article-title":"Influence of nanosecond pulsed laser irradiance on the viability of nanoparticle-loaded cells: implications for safety of contrast-enhanced photoacoustic imaging","volume":"24","author":"Bayer","year":"2013","journal-title":"Nanotechnology"},{"key":"10.1016\/j.nano.2016.08.007_bb0125","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.addr.2011.02.001","article-title":"Physical and chemical stability of drug nanoparticles","volume":"63","author":"Wu","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2016.08.007_bb0130","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.2217\/nnm.15.48","article-title":"Therapeutic and safety considerations of nanoparticle-mediated drug delivery in nanoparticle-mediated drug delivery in pregnancy","volume":"10","author":"Jeffrey","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2016.08.007_bb0135","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.colsurfb.2013.06.004","article-title":"Paclitaxel nanosuspensions coated with P-gp inhibitory surfactants: I. Acute toxicity and pharmacokinetics studies","volume":"111","author":"Gao","year":"2013","journal-title":"Colloids Surf B"},{"key":"10.1016\/j.nano.2016.08.007_bb0140","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/adma.200600222","article-title":"Porous, hollow, and ball-in-ball metal oxide microspheres: preparation, endocytosis, and cytotoxicity","volume":"18","author":"Suh","year":"2006","journal-title":"Adv Mater"},{"key":"10.1016\/j.nano.2016.08.007_bb0145","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ijpharm.2014.05.052","article-title":"Development and comparison of intramuscularly long-acting paliperidone palmitate nanosuspensions with different particle size","volume":"472","author":"Leng","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0150","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.colsurfb.2012.09.006","article-title":"In vitro and in vivo evaluation of riccardin D nanosuspensions with different particle size","volume":"102","author":"Liu","year":"2013","journal-title":"Colloids Surf B"},{"key":"10.1016\/j.nano.2016.08.007_bb0155","doi-asserted-by":"crossref","first-page":"8692","DOI":"10.1038\/ncomms9692","article-title":"Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug","volume":"6","author":"Miller","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2016.08.007_bb0160","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijpharm.2007.02.030","article-title":"Itraconazole IV nanosuspension enhances efficacy through altered pharmacokinetics in the rat","volume":"339","author":"Rabinow","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0165","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.tox.2009.08.002","article-title":"Comparative pulmonary toxicity study of nano-TiO(2) particles of different sizes and agglomerations in rats: different short- and long-term post-instillation results","volume":"264","author":"Kobayashi","year":"2009","journal-title":"Toxicology"},{"key":"10.1016\/j.nano.2016.08.007_bb0170","doi-asserted-by":"crossref","first-page":"9984","DOI":"10.1016\/j.biomaterials.2014.08.042","article-title":"Intra-articular delivery of kartogenin-conjugated chitosan nano\/microparticles for cartilage regeneration","volume":"35","author":"Kang","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2016.08.007_bb0175","doi-asserted-by":"crossref","first-page":"8278","DOI":"10.3390\/s120608278","article-title":"Atomic force microscopy as a tool applied to nano\/biosensors","volume":"12","author":"Steffens","year":"2012","journal-title":"Sensors (Basel)"},{"key":"10.1016\/j.nano.2016.08.007_bb0180","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1039\/c1an15313g","article-title":"Nanoparticle microinjection and Raman spectroscopy as tools for nanotoxicology studies","volume":"136","author":"Candeloro","year":"2011","journal-title":"Analyst"},{"key":"10.1016\/j.nano.2016.08.007_bb0185","doi-asserted-by":"crossref","first-page":"10264","DOI":"10.1039\/C4NR02008A","article-title":"Transport across the cell-membrane dictates nanoparticle fate and toxicity: a new paradigm in nanotoxicology","volume":"6","author":"Guarnieri","year":"2014","journal-title":"Nanoscale"},{"key":"10.1016\/j.nano.2016.08.007_bb0190","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1021\/nn500278q","article-title":"Core-Shell structured silicon nanoparticles@TiO2\u2013x\/carbon mesoporous microfiber composite as a safe and high-performance lithium-ion battery anode","volume":"8","author":"Jeong","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2016.08.007_bb0195","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1556-276X-9-146","article-title":"Carboxymethyl chitosan-folic acid-conjugated Fe3O4@SiO2 as a safe and targeting antitumor nanovehicle in vitro","volume":"9","author":"Li","year":"2014","journal-title":"Nanoscale Res Lett"},{"key":"10.1016\/j.nano.2016.08.007_bb0200","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1517\/17425247.2014.913568","article-title":"Advantages and risks of nanotechnologies in cancer patients and occupationally exposed workers","volume":"11","author":"Lamberti","year":"2014","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.nano.2016.08.007_bb0205","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/17435390.2010.489724","article-title":"Particle and nanoparticle interactions with fibrinogen: the importance of aggregation in nanotoxicology","volume":"5","author":"Kendall","year":"2011","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.nano.2016.08.007_bb0210","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijpharm.2007.12.016","article-title":"Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions","volume":"355","author":"Gao","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0215","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijpharm.2007.08.036","article-title":"Preparation and characterization of intravenously injectable nimodipine nanosuspension","volume":"350","author":"Xiong","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0220","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pneurobio.2008.09.009","article-title":"Nanotechnology, nanotoxicology, and neuroscience","volume":"87","author":"Suh","year":"2009","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.nano.2016.08.007_bb0225","doi-asserted-by":"crossref","first-page":"7022","DOI":"10.1016\/j.biomaterials.2014.04.066","article-title":"Dose ranging, expanded acute toxicity and safety pharmacology studies for intravenously administered functionalized graphene nanoparticle formulations","volume":"35","author":"Kanakia","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2016.08.007_bb0230","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijpharm.2010.12.027","article-title":"Physical stability of nanosuspensions: investigation of the role of stabilizers on Ostwald ripening","volume":"406","author":"Verma","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0235","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ijpharm.2012.11.033","article-title":"Food proteins as novel nanosuspension stabilizers for poorly water-soluble drugs","volume":"441","author":"He","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0240","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijpharm.2010.06.020","article-title":"Miconazole nanosuspensions: influence of formulation variables on particle size reduction and physical stability","volume":"396","author":"Cerdeira","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0245","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijpharm.2016.06.045","article-title":"Development and in vitro evaluation of zeta potential changing self-emulsifying drug delivery systems for enhanced mucus permeation","volume":"510","author":"Suchaoin","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0250","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jcis.2010.02.028","article-title":"Influence of the zeta potential on the sorption and toxicity of iron oxide nanoparticles on S. cerevisiae and E. coli","volume":"347","author":"Schwegmann","year":"2010","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.nano.2016.08.007_bb0255","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijpharm.2013.01.019","article-title":"Bottom-up approaches for preparing drug nanocrystals: formulations and factors affecting particle size","volume":"453","author":"Sinha","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0260","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jcis.2014.12.032","article-title":"Use of alginate, chitosan and cellulose nanocrystals as emulsion stabilizers in the synthesis of biodegradable polymeric nanoparticles","volume":"445","author":"Rescignano","year":"2015","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.nano.2016.08.007_bb0265","article-title":"A novel method for synthesizing PEGylated chitosan nanoparticles: strategy, preparation, and in vitro analysis","volume":"485-94","author":"Prakash","year":"2011","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.nano.2016.08.007_bb0270","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1016\/j.biomaterials.2009.04.003","article-title":"Biocompatibility of injectable chitosan-phospholipid implant systems","volume":"30","author":"De Souza","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2016.08.007_bb0275","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jddst.2015.07.012","article-title":"Particle size control and the interactions between drug and stabilizers in an amorphous nanosuspension system","volume":"29","author":"Bi","year":"2015","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.nano.2016.08.007_bb0280","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/jps.24266","article-title":"Systematic screening of different surface modifiers for the production of physically stable nanosuspensions","volume":"104","author":"Lestari","year":"2015","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nano.2016.08.007_bb0285","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jbiotec.2004.06.007","article-title":"Challenges and solutions for the delivery of biotech drugs \u2013 a review of drug nanocrystal technology and lipid nanoparticles","volume":"113","author":"Muller","year":"2004","journal-title":"J Biotechnol"},{"key":"10.1016\/j.nano.2016.08.007_bb0290","series-title":"Advances in Planar Lipid Bilayers and Liposomes","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/bs.adplan.2014.11.001","article-title":"Chapter five \u2013 Steric Stabilizers for Cubic Phase Lyotropic Liquid Crystal Nanodispersions (Cubosomes)","author":"Chong","year":"2015"},{"key":"10.1016\/j.nano.2016.08.007_bb0295","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jcis.2014.12.064","article-title":"Study on metal nanoparticles synthesis and orientation of gemini surfactant molecules used as stabilizer","volume":"445","author":"Tiwari","year":"2015","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.nano.2016.08.007_bb0300","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijpharm.2011.09.041","article-title":"Surface modified nevirapine nanosuspensions for viral reservoir targeting: in vitro and in vivo evaluation","volume":"421","author":"Shegokar","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0305","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.colsurfa.2015.10.010","article-title":"Unusual transient stabilization with stabilizers and morphology of co-nanoparticles","volume":"488","author":"Khan","year":"2016","journal-title":"Colloids Surf A"},{"key":"10.1016\/j.nano.2016.08.007_bb0310","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijpharm.2008.07.023","article-title":"Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products","volume":"364","author":"Van Eerdenbrugh","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0315","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijpharm.2015.11.047","article-title":"Simple low-cost miniaturization approach for pharmaceutical nanocrystals production","volume":"501","author":"Romero","year":"2015","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0320","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijpharm.2014.06.018","article-title":"A combined bottom-up\/top-down approach to prepare a sterile injectable nanosuspension","volume":"472","author":"Hu","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0325","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.powtec.2014.02.011","article-title":"A comparative study of top-down and bottom-up approaches for the preparation of nanosuspensions of glipizide","volume":"256","author":"Mahesh","year":"2014","journal-title":"Powder Technol"},{"key":"10.1016\/j.nano.2016.08.007_bb0330","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijpharm.2010.07.044","article-title":"Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives","volume":"399","author":"Shegokar","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0335","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1672-2515(07)60110-9","article-title":"Mass production of nanoparticles by high gravity reactive precipitation technology with low cost","volume":"1","author":"Chen","year":"2003","journal-title":"China Particuol"},{"key":"10.1016\/j.nano.2016.08.007_bb0340","doi-asserted-by":"crossref","first-page":"14340","DOI":"10.1016\/j.ceramint.2015.07.067","article-title":"Synthesis and characterization of hydroxyapatite nanoparticles prepared by a high-gravity precipitation method","volume":"41","author":"Peng","year":"2015","journal-title":"Ceram Int"},{"key":"10.1016\/j.nano.2016.08.007_bb0345","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ejps.2012.12.026","article-title":"Preparation of apigenin nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement","volume":"48","author":"Zhang","year":"2013","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2016.08.007_bb0350","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ejps.2010.04.006","article-title":"Preparation of stable nitrendipine nanosuspensions using the precipitation\u2013ultrasonication method for enhancement of dissolution and oral bioavailability","volume":"40","author":"Xia","year":"2010","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2016.08.007_bb0355","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijpharm.2012.09.020","article-title":"Enhanced dissolution and oral bioavailability of aripiprazole nanosuspensions prepared by nanoprecipitation\/homogenization based on acid\u2013base neutralization","volume":"438","author":"Xu","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0360","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijpharm.2011.03.050","article-title":"Nanosuspensions of poorly soluble drugs: preparation and development by wet milling","volume":"411","author":"Liu","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0365","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ijpharm.2011.09.003","article-title":"Process optimization of a novel production method for nanosuspensions using design of experiments (DoE)","volume":"420","author":"Salazar","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0370","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijpharm.2009.01.024","article-title":"Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour","volume":"373","author":"Lai","year":"2009","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0375","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.cossms.2012.10.004","article-title":"Nanocrystals for the parenteral delivery of poorly water-soluble drugs","volume":"16","author":"Sun","year":"2012","journal-title":"Curr Opin Solid State Mater"},{"key":"10.1016\/j.nano.2016.08.007_bb0380","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.nano.2014.03.017","article-title":"Challenges facing sterilization and depyrogenation of nanoparticles: effects on structural stability and biomedical applications","volume":"10","author":"Vetten","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2016.08.007_bb0385","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.jbiomech.2008.07.012","article-title":"Mechanical strength of bone allografts subjected to chemical sterilization and other terminal processing methods","volume":"41","author":"Mikhael","year":"2008","journal-title":"J Biomech"},{"key":"10.1016\/j.nano.2016.08.007_bb0390","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jmbbm.2014.08.017","article-title":"Mechanical properties of acellular mouse lungs after sterilization by gamma irradiation","volume":"40","author":"Uriarte","year":"2014","journal-title":"J Mech Behav Biomed"},{"key":"10.1016\/j.nano.2016.08.007_bb0395","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.radphyschem.2013.06.028","article-title":"Radiation stability of polypropylene\/lead zirconate composites","volume":"94","author":"Burnea","year":"2014","journal-title":"Radiat Phys Chem"},{"key":"10.1016\/j.nano.2016.08.007_bb0400","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.radphyschem.2016.01.021","article-title":"Irradiation as an alternative route for protein crosslinking: cosolvent free BSA nanoparticles","volume":"124","author":"Varca","year":"2016","journal-title":"Radiat Phys Chem"},{"key":"10.1016\/j.nano.2016.08.007_bb0405","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.polymdegradstab.2014.04.029","article-title":"Light stabilizer-conjugated\u2013stearylate chitosan nanoparticles: a bio-based additive for free radical stabilization of healthcare plastics under irradiation","volume":"109","author":"Rattanawongwiboon","year":"2014","journal-title":"Polym Degrad Stabil"},{"key":"10.1016\/j.nano.2016.08.007_bb0410","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ajps.2013.07.011","article-title":"Liposomes as sterile preparations and limitations of sterilisation techniques in liposomal manufacturing","volume":"8","author":"Toh","year":"2013","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.nano.2016.08.007_bb0415","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ymeth.2006.05.025","article-title":"Lyophilisation and sterilisation of liposomal vaccines to produce stable and sterile products","volume":"40","author":"Mohammed","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.nano.2016.08.007_bb0420","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-5173(96)04822-3","article-title":"Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles","volume":"148","author":"Cavalli","year":"1997","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0425","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejpb.2014.05.014","article-title":"Nanosuspension for the delivery of a poorly soluble anti-cancer kinase inhibitor","volume":"88","author":"Danhier","year":"2014","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0430","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.nano.2015.09.006","article-title":"Shape regulated anticancer activities and systematic toxicities of drug nanocrystals in vivo","volume":"12","author":"Zhou","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2016.08.007_bb0435","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.colsurfb.2013.12.056","article-title":"Honokiol nanosuspensions: preparation, increased oral bioavailability and dramatically enhanced biodistribution in the cardio-cerebro-vascular system","volume":"116","author":"Han","year":"2014","journal-title":"Colloids Surf B"},{"key":"10.1016\/j.nano.2016.08.007_bb0440","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijbiomac.2014.03.006","article-title":"Dissolution and oral absorption of pranlukast nanosuspensions stabilized by hydroxypropylmethyl cellulose","volume":"67","author":"I-h","year":"2014","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.nano.2016.08.007_bb0445","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijpharm.2012.09.034","article-title":"Drug nanocrystals in the commercial pharmaceutical development process","volume":"453","author":"M\u00f6schwitzer","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0450","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ajps.2014.08.005","article-title":"Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs","volume":"10","author":"Junyaprasert","year":"2015","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.nano.2016.08.007_bb0455","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ijpharm.2014.09.008","article-title":"Controlled delivery of carvedilol nanosuspension from osmotic pump capsule: in vitro and in vivo evaluation","volume":"475","author":"Liu","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0460","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijpharm.2008.02.011","article-title":"Inhaled nanoparticles \u2013 a current review","volume":"356","author":"Yang","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0465","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.etap.2011.02.005","article-title":"Development of nano alpha-ketoglutarate nebulization formulation and its pharmacokinetic and safety evaluation in healthy human volunteers for cyanide poisoning","volume":"31","author":"Sultana","year":"2011","journal-title":"Environ Toxicol Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0470","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ejpb.2010.12.025","article-title":"The influence of pulmonary surfactant on nanoparticulate drug delivery systems","volume":"77","author":"Schleh","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0475","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.fct.2015.08.008","article-title":"Acute and subacute pulmonary toxicity and mortality in mice after intratracheal instillation of ZnO nanoparticles in three laboratories","volume":"85","author":"Jacobsen","year":"2015","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.nano.2016.08.007_bb0480","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jconrel.2011.12.004","article-title":"Controlled pulmonary drug and gene delivery using polymeric nano-carriers","volume":"161","author":"Beck-Broichsitter","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2016.08.007_bb0485","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijpharm.2011.01.032","article-title":"Evaluation of a crystalline nanosuspension: polymorphism, process induced transformation and in vivo studies","volume":"408","author":"Sharma","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0490","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0378-5173(95)00122-Y","article-title":"Particle size reduction for improvement of oral bioavailability of hydrophobic drugs I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs","volume":"125","author":"Gary","year":"1995","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0495","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jphotobiol.2015.05.018","article-title":"Preparation and characterization of injectable Mitoxantrone poly (lactic acid)\/fullerene implants for in vivo chemo-photodynamic therapy","volume":"149","author":"Li","year":"2015","journal-title":"J Photochem Photobiol B"},{"key":"10.1016\/j.nano.2016.08.007_bb0500","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ejpb.2012.04.008","article-title":"Injectable poly(organophosphazene)-camptothecin conjugate hydrogels: synthesis, characterization, and antitumor activities","volume":"81","author":"Cho","year":"2012","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0505","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijpharm.2013.04.005","article-title":"Riboflavin laurate nanosuspensions as an intramuscular injection for long-term riboflavin supplementation","volume":"450","author":"Du","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0510","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ejps.2013.03.010","article-title":"Oily nanosuspension for long-acting intramuscular delivery of curcumin didecanoate prodrug: preparation, characterization and in vivo evaluation","volume":"49","author":"Wei","year":"2013","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2016.08.007_bb0515","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.nano.2010.07.003","article-title":"Nanosuspension: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to amphotericin B","volume":"7","author":"Das","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2016.08.007_bb0520","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/138920007779815977","article-title":"Ocular disposition, pharmacokinetics, efficacy and safety of nanoparticle-formulated ophthalmic drugs","volume":"8","author":"Bu","year":"2007","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.nano.2016.08.007_bb0525","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ajps.2013.09.002","article-title":"Prodrugs incorporated into nanotechnology-based drug delivery systems for possible improvement in bioavailability of ocular drugs delivery","volume":"8","author":"Ye","year":"2013","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.nano.2016.08.007_bb0530","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jconrel.2010.10.007","article-title":"Hydrocortisone nanosuspensions for ophthalmic delivery: a comparative study between microfluidic nanoprecipitation and wet milling","volume":"149","author":"Ali","year":"2011","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2016.08.007_bb0535","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ijbiomac.2015.11.070","article-title":"Chitosan-based nanoparticles for rosmarinic acid ocular delivery \u2013 in vitro tests","volume":"84","author":"da Silva","year":"2016","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.nano.2016.08.007_bb0540","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.nano.2009.02.003","article-title":"Nanomedicines for ocular NSAIDs: safety on drug delivery","volume":"5","author":"Araujo","year":"2009","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2016.08.007_bb0545","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.ajo.2014.01.027","article-title":"In vivo intraocular distribution and safety of periocular nanoparticle carboplatin for treatment of advanced retinoblastoma in humans","volume":"157","author":"Kalita","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.nano.2016.08.007_bb0550","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijpharm.2013.06.024","article-title":"Drug delivery to the ocular posterior segment using lipid emulsion via eye drop administration: effect of emulsion formulations and surface modification","volume":"453","author":"Ying","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0555","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ejpb.2015.02.019","article-title":"Nanotherapies for the treatment of ocular diseases","volume":"95","author":"Reimondez-Troiti\u00f1o","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0560","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ijpharm.2014.11.001","article-title":"Lipid based nanocarrier system for the potential oral delivery of decitabine: formulation design, characterization, ex vivo, and in vivo assessment","volume":"477","author":"Neupane","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0565","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ijbiomac.2014.03.022","article-title":"Donepezil nanosuspension intended for nose to brain targeting: in vitro and in vivo safety evaluation","volume":"67","author":"Bhavna","year":"2014","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.nano.2016.08.007_bb0570","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijpharm.2013.10.007","article-title":"Nanosuspension improves tretinoin photostability and delivery to the skin","volume":"458","author":"Lai","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.08.007_bb0575","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/637976","article-title":"Bisphosphonates and cancer: what opportunities from nanotechnology?","volume":"2013","author":"De Rosa","year":"2013","journal-title":"J Drug Deliv"},{"key":"10.1016\/j.nano.2016.08.007_bb0580","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jconrel.2011.06.001","article-title":"Targeted drug delivery to tumors: myths, reality and possibility","volume":"153","author":"Bae","year":"2011","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2016.08.007_bb0585","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jconrel.2013.06.039","article-title":"Biodistribution and bioimaging studies of hybrid paclitaxel nanocrystals: lessons learned of the EPR effect and image-guided drug delivery","volume":"172","author":"Hollis","year":"2013","journal-title":"J Control Release"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963416301150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963416301150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T21:58:50Z","timestamp":1536443930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963416301150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":117,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1549963416301150"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2016.08.007","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of nanosuspensions in drug delivery","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2016.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}